Ifeoluwapo Oyebola Asekun-Olarinmoye
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ifeoluwapo Oyebola Asekun-Olarinmoye has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Grace Eleojo Itodo
Department of Microbiology, Federal Teaching Hospital, Lokoja, Kogi State, Nigeria
2 shared publications - Michael Unata Iduh
Department of Medical Microbiology, School of Medical Laboratory Science, Usmanu Danfodiyo University, Sokoto, Sokoto State Nigeria
2 shared publications - Seyi Samson Enitan
Department of Medical Laboratory Science, Babcock University, Ilishan-Remo, Ogun State, Nigeria
2 shared publications - Ameh Raphael Adole
Department of Infectious disease, Clinton Health Access Initiative, FCT-Abuja, Nigeria
1 shared publication - Ameh Raphael Adole
Infectious Diseases Department, Clinton Health Access Initiative, FCT-Abuja, Nigeria
1 shared publication - Ayomide Oluwatobiloba Okuneye
Department of Medical Laboratory Science, School of Public and Allied Health, Babcock University, Ilishan-Remo 121109, Ogun State, Nigeria
1 shared publication
Latest Publications
- Open Access
- 28 December 2024
- Published by Maad Rayan Publishing Company in Avicenna Journal of Clinical Microbiology and Infection
- Vol. 11 (4) , 182-190
Advancing Toward a Hepatitis C-Free World: Emerging Therapies, Persistent Challenges, and Future Prospects
Recent advancements in the treatment of hepatitis C virus (HCV) infection have significantly advanced the goal of achieving a hepatitis C-free world. The introduction of direct-acting antivirals (DAAs) has revolutionized treatment, offering over 95% cure rates, shorter treatment durations, and fewer side effects. Pan-genotypic regimens, such as sofosbuvir/velpatasvir, have further simplified treatment by being effective across all HCV genotypes. Despite these advancements, substantial challenges persist globally. An estimated 50 million people are living with chronic HCV worldwide, yet many remain undiagnosed, particularly in low- and middle-income countries, where there is limited healthcare infrastructure. High treatment costs further restrict access to these life-saving therapies. Reinfection rates remain high among certain populations, such as people who inject drugs (PWIDs), and stigma continues to deter individuals from seeking testing and treatment. To advance HCV elimination, future efforts must prioritize universal screening, affordable treatment, improved diagnostic technologies, and intensified research into vaccine development. Strengthened global and local collaboration is essential to overcome these challenges and reduce the global HCV burden.
- 28 December 2024
- Published by Maad Rayan Publishing Company in Avicenna Journal of Clinical Microbiology and Infection
- Vol. 11 (4) , 182-190
Open AccessAdvancing Toward a Hepatitis C-Free World: Emerging Therapies, Persistent Challenges, and Future Prospects
Recent advancements in the treatment of hepatitis C virus (HCV) infection have significantly advanced the goal of achieving a hepatitis C-free world. The introduction of direct-acting antivirals (DAAs) has revolutionized treatment, offering over 95% cure rates, shorter treatment durations, and fewer side effects. Pan-genotypic regimens, such as sofosbuvir/velpatasvir, have further simplified treatment by being effective across all HCV genotypes. Despite these advancements, substantial challenges persist globally. An estimated 50 million people are living with chronic HCV worldwide, yet many remain undiagnosed, particularly in low- and middle-income countries, where there is limited healthcare infrastructure. High treatment costs further restrict access to these life-saving therapies. Reinfection rates remain high among certain populations, such as people who inject drugs (PWIDs), and stigma continues to deter individuals from seeking testing and treatment. To advance HCV elimination, future efforts must prioritize universal screening, affordable treatment, improved diagnostic technologies, and intensified research into vaccine development. Strengthened global and local collaboration is essential to overcome these challenges and reduce the global HCV burden.
- Open Access
- 20 November 2024
- Published by Egyptian Knowledge Bank in Afro-Egyptian Journal of Infectious and Endemic Diseases
- p. 375-395
Combating Measles in Nigeria: Epidemiological Trends, Drivers, Barriers and Public Health Interventions
Measles remains a significant public health challenge in Nigeria, contributing to substantial morbidity and mortality among children despite the availability of effective vaccines. This narrative review aims to synthesize current literature on the epidemiological trends, drivers, barriers, and public health interventions related to measles control in Nigeria. A comprehensive search was conducted across Google Scholar, Scopus, and PubMed for articles published between 2008 and 2024. The search strategy utilized keywords such as “measles,” “Nigeria,” “epidemiology,” “vaccination,” and “public health interventions.” Articles were selected based on predetermined inclusion and exclusion criteria, focusing on studies that specifically addressed measles and its control measures in Nigeria. The review highlights fluctuating measles incidence with periodic outbreaks exacerbated by low immunization coverage, population displacement, and rapid urbanization. Suboptimal vaccination rates for both the first (MCV1) and second (MCV2) doses leave many children vulnerable. Barriers to effective control include misinformation, vaccine hesitancy, insecurity in conflict-affected regions, and logistical challenges in vaccine distribution. Public health interventions, including enhanced immunization campaigns, community engagement, and integrated health services, are essential for improving vaccination coverage and combating measles. Achieving effective measles control in Nigeria requires sustained commitment, adequate funding, and international collaboration to ensure the health and well-being of Nigerian children.
- 20 November 2024
- Published by Egyptian Knowledge Bank in Afro-Egyptian Journal of Infectious and Endemic Diseases
- p. 375-395
Open AccessCombating Measles in Nigeria: Epidemiological Trends, Drivers, Barriers and Public Health Interventions
Measles remains a significant public health challenge in Nigeria, contributing to substantial morbidity and mortality among children despite the availability of effective vaccines. This narrative review aims to synthesize current literature on the epidemiological trends, drivers, barriers, and public health interventions related to measles control in Nigeria. A comprehensive search was conducted across Google Scholar, Scopus, and PubMed for articles published between 2008 and 2024. The search strategy utilized keywords such as “measles,” “Nigeria,” “epidemiology,” “vaccination,” and “public health interventions.” Articles were selected based on predetermined inclusion and exclusion criteria, focusing on studies that specifically addressed measles and its control measures in Nigeria. The review highlights fluctuating measles incidence with periodic outbreaks exacerbated by low immunization coverage, population displacement, and rapid urbanization. Suboptimal vaccination rates for both the first (MCV1) and second (MCV2) doses leave many children vulnerable. Barriers to effective control include misinformation, vaccine hesitancy, insecurity in conflict-affected regions, and logistical challenges in vaccine distribution. Public health interventions, including enhanced immunization campaigns, community engagement, and integrated health services, are essential for improving vaccination coverage and combating measles. Achieving effective measles control in Nigeria requires sustained commitment, adequate funding, and international collaboration to ensure the health and well-being of Nigerian children.
- Open Access
- 1 January 2023
- Published by SAGE Publications in INQUIRY: The Journal of Health Care Organization, Provision, and Financing
- Vol. 60
Factors Affecting Anemia in Pregnancy Women in Ibeju-Lekki, Lagos State, Nigeria
Anemia progresses due to low red blood cells counts or hemoglobin. The World Health Organization (WHO) has suggested the condition to be a serious global public health problem that affects pregnant women worldwide. Anemic pregnant women may suffer post-partum hemorrhage, pre-term delivery, seizures, and severe cases of anemia that potentially lead to cardiac failure or death. However, it is pertinent for pregnant women and health service providers to have the adequate knowledge about the factors associated with anemia in pregnancy. Thus, this study assessed the factors associated with anemia in pregnancy women attending primary healthcare (PHC) centers in Ibeju-Lekki Local government area, Lagos state. This study employed descriptive cross-sectional design using multi-stage sampling method to recruit 295 pregnant women into the study. Data were collected using a semi-structured, self-administered questionnaire. The recruited participants (56.6%) were majorly in their third trimester, of which their mean age was 28.7 ± 5.9 years. About 80.7% of the participants were married, having a mean knowledge score of 6.6 ± 3.2. More than half of respondents (56.3%) were anemic and had a poor knowledge (50.5%) of anemia in pregnancy. The mean hemoglobin concentration within the population was 11.06 ± 0.73 g/dl with a range of 8.3 to 12.0. There was no significant association between the respondents’ knowledge of anemia in pregnancy and anemic status (X2 = 0.549; P = .45). However, this study observed a significant association between dietary diversity score and anemic status (X2 = 8.66; P = .01) and the trimester status of respondents’ first antenatal visit (X2 = 9.603; P = .008). The study concluded that anemia in pregnancy was associated with maternal factors such as their first antenatal visit and the dietary diversity score. Due to this, proper education of pregnant women on anemia by health workers during antenatal clinics or visits should be prioritize to improve their anemia status.
- 1 January 2023
- Published by SAGE Publications in INQUIRY: The Journal of Health Care Organization, Provision, and Financing
- Vol. 60
Open AccessFactors Affecting Anemia in Pregnancy Women in Ibeju-Lekki, Lagos State, Nigeria
Anemia progresses due to low red blood cells counts or hemoglobin. The World Health Organization (WHO) has suggested the condition to be a serious global public health problem that affects pregnant women worldwide. Anemic pregnant women may suffer post-partum hemorrhage, pre-term delivery, seizures, and severe cases of anemia that potentially lead to cardiac failure or death. However, it is pertinent for pregnant women and health service providers to have the adequate knowledge about the factors associated with anemia in pregnancy. Thus, this study assessed the factors associated with anemia in pregnancy women attending primary healthcare (PHC) centers in Ibeju-Lekki Local government area, Lagos state. This study employed descriptive cross-sectional design using multi-stage sampling method to recruit 295 pregnant women into the study. Data were collected using a semi-structured, self-administered questionnaire. The recruited participants (56.6%) were majorly in their third trimester, of which their mean age was 28.7 ± 5.9 years. About 80.7% of the participants were married, having a mean knowledge score of 6.6 ± 3.2. More than half of respondents (56.3%) were anemic and had a poor knowledge (50.5%) of anemia in pregnancy. The mean hemoglobin concentration within the population was 11.06 ± 0.73 g/dl with a range of 8.3 to 12.0. There was no significant association between the respondents’ knowledge of anemia in pregnancy and anemic status (X2 = 0.549; P = .45). However, this study observed a significant association between dietary diversity score and anemic status (X2 = 8.66; P = .01) and the trimester status of respondents’ first antenatal visit (X2 = 9.603; P = .008). The study concluded that anemia in pregnancy was associated with maternal factors such as their first antenatal visit and the dietary diversity score. Due to this, proper education of pregnant women on anemia by health workers during antenatal clinics or visits should be prioritize to improve their anemia status.